EPAS1
Endothelial PAS domain-containing protein 1
Also known as: bHLHe73, EPAS1_HUMAN, HIF2A, HLF, MOP2, PASD2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99814
- Gene
- EPAS1
- Ensembl
- ENSG00000116016
- Chromosome
- 2
- Canonical length
- 870 aa
- Protein class
- Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Actin filaments,Cytokinetic bridge,Cytosol
OverviewNCBI Gene
This gene encodes a transcription factor involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels. Mutations in this gene are associated with erythrocytosis familial type 4. [provided by RefSeq, Nov 2009]
Canonical amino-acid sequenceUniProt
870 residues, UniProt reviewed canonical sequence.
>Q99814|EPAS1
1 MTADKEKKRS SSERRKEKSR DAARCRRSKE TEVFYELAHE LPLPHSVSSH LDKASIMRLA
61 ISFLRTHKLL SSVCSENESE AEADQQMDNL YLKALEGFIA VVTQDGDMIF LSENISKFMG
121 LTQVELTGHS IFDFTHPCDH EEIRENLSLK NGSGFGKKSK DMSTERDFFM RMKCTVTNRG
181 RTVNLKSATW KVLHCTGQVK VYNNCPPHNS LCGYKEPLLS CLIIMCEPIQ HPSHMDIPLD
241 SKTFLSRHSM DMKFTYCDDR ITELIGYHPE ELLGRSAYEF YHALDSENMT KSHQNLCTKG
301 QVVSGQYRML AKHGGYVWLE TQGTVIYNPR NLQPQCIMCV NYVLSEIEKN DVVFSMDQTE
361 SLFKPHLMAM NSIFDSSGKG AVSEKSNFLF TKLKEEPEEL AQLAPTPGDA IISLDFGNQN
421 FEESSAYGKA ILPPSQPWAT ELRSHSTQSE AGSLPAFTVP QAAAPGSTTP SATSSSSSCS
481 TPNSPEDYYT SLDNDLKIEV IEKLFAMDTE AKDQCSTQTD FNELDLETLA PYIPMDGEDF
541 QLSPICPEER LLAENPQSTP QHCFSAMTNI FQPLAPVAPH SPFLLDKFQQ QLESKKTEPE
601 HRPMSSIFFD AGSKASLPPC CGQASTPLSS MGGRSNTQWP PDPPLHFGPT KWAVGDQRTE
661 FLGAAPLGPP VSPPHVSTFK TRSAKGFGAR GPDVLSPAMV ALSNKLKLKR QLEYEEQAFQ
721 DLSGGDPPGG STSHLMWKRM KNLRGGSCPL MPDKPLSANV PNDKFTQNPM RGLGHPLRHL
781 PLPQPPSAIS PGENSKSRFP PQCYATQYQD YSLSSAHKVS GMASRLLGPS FESYLLPELT
841 RYDCEVNVPV LGSSTLLQGG DLLRALDQATLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPAS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 419 nTPM
Expression across tissuesHPA
Tissue
- placenta: 419 nTPM
- lung: 389 nTPM
- adipose tissue: 278 nTPM
- blood vessel: 273 nTPM
- breast: 157 nTPM
- tongue: 144 nTPM
Single-cell type
- vascular endothelial cells: 1,356 nCPM
- extravillous trophoblasts: 1,049 nCPM
- syncytiotrophoblasts: 997 nCPM
- respiratory secretory cells: 722 nCPM
- respiratory basal cells: 657 nCPM
- pericytes: 619 nCPM
Immune cell
- basophil: 21 nTPM
- eosinophil: 8.4 nTPM
- NK-cell: 0.8 nTPM
- memory CD4 T-cell: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
Brain region
- choroid plexus: 303 nTPM
- thalamus: 173 nTPM
- medulla oblongata: 137 nTPM
- pons: 137 nTPM
- midbrain: 123 nTPM
- amygdala: 122 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EPAS1.
Disease | AllUniProt
Conditions EPAS1 is implicated in, by any mechanism.
- Erythrocytosis, familial, 4 (ECYT4) MIM:611783
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 1,835 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Erythrocytosis, familial, 4
- Erythrocytosis, familial, 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.6
- gnomAD missense Z
- -0.15
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- blood vessel remodeling
- cellular response to hypoxia
- embryonic placenta development
- epithelial cell maturation
- erythrocyte differentiation
- intracellular oxygen homeostasis
- lung development
- mitochondrion organization
- mRNA transcription by RNA polymerase II
- multicellular organismal-level iron ion homeostasis
- myoblast fate commitment
- norepinephrine metabolic process
- positive regulation of cold-induced thermogenesis
- positive regulation of transcription by RNA polymerase II
- regulation of heart rate
- regulation of protein neddylation
- regulation of transcription by RNA polymerase II
- response to hypoxia
- response to oxidative stress
- signal transduction
- surfactant homeostasis
- visual perception
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein heterodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription coactivator binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PAS domain
- Nuclear translocator
- PAC motif
- Myc-type, basic helix-loop-helix (bHLH) domain
- PAS fold
- HIF-1 alpha, C-terminal transactivation domain
- Hypoxia-inducible factor, alpha subunit-like
- PAS domain superfamily
- Helix-loop-helix DNA-binding domain superfamily
- PAS fold
- HIF-1 alpha C terminal transactivation domain
- Hypoxia-inducible factor-1
- PAS domain
- Hypoxia-inducible factor 1-alpha bHLH domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EPAS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPAS1 as an antibody target. Whether an autoantibody or antibody against EPAS1 could matter depends on whether native EPAS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPAS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EPAS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...